Hybrid arc palliative radiation therapy for metastasis
Part of Cancer clinical trials.
This trial tests a new radiation technique for people with cancer that has spread to bones or soft tissues in the chest, belly, or pelvis. The goal is to safely deliver effective palliative radiation to ease symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread (metastatic) to bones or soft tissues, confirmed by a scan.
- You need palliative radiation for tumors in your chest, abdomen, or pelvis.
- You are 18 years or older.
- You agree to use birth control during the study and for 90 days after treatment.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a higher dose of radiation to shrink large tumors and relieve pain in people with advanced cancer. It aims to improve quality of life by targeting up to three large tumors with a single treatment.
This Phase 2 study compares a one-time, high-dose radiation treatment (SBRT) with the usual, shorter-course palliative radiation. The goal is to see which approach better relieves symptoms from metastatic (spread) cancer.
This trial tests a single session of radiation therapy to relieve pain and improve stability in up to two bone spots where cancer has spread. The goal is to make treatment faster and more convenient for patients.
This study looks at how a planned form of palliative radiation therapy treats certain solid cancers that have spread outside the brain to larger soft-tissue areas. It may help shrink tumors and relieve symptoms, but it also asks you to meet specific safety and treatment-timing rules.
This trial studies whether adding a focused, comfort-focused form of radiation (SBRT) to pembrolizumab can help people with stage IV breast cancer that cannot be removed with surgery. You may be eligible if you can receive palliative SBRT and have measurable tumors, and if you meet prior-therapy and blood/health criteria.
This trial tests whether a precise type of radiation can control cancer that has spread to a limited number of sites (1–10) while you also have the main tumor. It aims to improve outcomes by treating all visible cancer spots with stereotactic ablative radiotherapy.
Hear when a new Palliative Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.